v3.26.1
SEGMENTS, GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER DATA (Tables)
6 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]  
Schedule of financial information with respect to single operating segment
    Six months ended
June 30,
 
    2026     2025  
    Unaudited  
             
Total Revenues     4,778       3,541  
                 
Less:                
           Preclinical     7,858       6,659  
           Clinical     8,824       6,982  
           SG&A     5,438       4,851  
           Financial income, net     (3,189 )     (2,314 )
           Taxes on income     12       14  
           Other segment expenses*     510       1,872  
                 
Net loss     (14,675 )     (14,523 )

 

*Other segment expense during the six months ended June 30, 2026 and 2025 includes share-based compensation and other adjustments.

Schedule of total revenues and long-lived assets by geographic area
    Six months ended
June 30,
 
    2026     2025  
    Unaudited  
Revenue from sales to customers:              
                 
United States   $ 4,778     $ 3,541  
Europe     -       -  
                 
Total revenues   $ 4,778     $ 3,541